| Trial ID: | L0047 |
| Source ID: | NCT03950882
|
| Associated Drug: |
PXL770
|
| Title: |
A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver
|
| Interventions: |
Drug: PXL770|Drug: Placebo
|
| Outcome Measures: |
PK parameters of PXL770|Plasma PK parameters of PXL770
|
| Sponsor/Collaborators: |
Poxel SA
|
| Gender: |
All
|
| Age: |
18 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
17
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
August 1, 2019
|
| Completion Date: |
March 31, 2020
|
| Results First Posted: |
--
|
| Last Update Posted: |
June 11, 2021
|
| Locations: |
High Point Clinical Trials Center, High Point, North Carolina, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT03950882
|
